Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue from awards $ 0 $ 881,705
Operating expenses:    
Research and development 16,136,826 36,445,285
General and administrative 18,698,619 20,425,444
Litigation Settlement 5,000,000 0
Total operating expenses 39,835,445 56,870,729
Operating loss (39,835,445) (55,989,024)
Other income (expense), net:    
Other income (expense), net (48,773) 11,899,992
Interest income (expense), net (2,132,091) (1,830,486)
Change in fair value of derivative liability 96,842 663,290
Foreign currency exchange gain (loss), net (427,436) (384,198)
Other income (expense), net (2,511,458) 10,348,598
Net loss $ (42,346,903) $ (45,640,426)
Net loss per share, basic $ (10.15) $ (11.15)
Net loss per share, diluted $ (10.15) $ (11.15)
Weighted average number of common shares outstanding, basic 4,170,675 4,094,935
Weighted average number of common shares outstanding, diluted 4,170,675 4,094,935
Comprehensive loss:    
Net loss $ (42,346,903) $ (45,640,426)
Other comprehensive income (loss):    
Change in unrealized gain (loss) on marketable debt securities (63,647) (62,445)
Total other comprehensive income (loss) (63,647) (62,445)
Total comprehensive loss $ (42,410,550) $ (45,702,871)